RESMED INC. DL-,004/ US7611521078 /
9/20/2024 9:43:51 PM | Chg. +2.500 | Volume | Bid9:50:01 PM | Ask9:50:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
219.700EUR | +1.15% | 4 Turnover: 876.200 |
-Bid Size: 80 | -Ask Size: 80 | 32.24 bill.EUR | - | - |
GlobeNewswire
8/28
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswire
8/15
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader ...
GlobeNewswire
7/25
NATIONAL CENTER ON SHAKEN BABY SYNDROME AND XEALTH INCREASE SPEED AND ACCESSIBILITY OF CRITICAL PARE...
GlobeNewswire
6/27
XEALTH LAUNCHES DEWEY, THE INDUSTRY’S FIRST PERFORMANCE-BASED, DIGITAL HEALTH BENCHMARKING TOOL
GlobeNewswire
6/10
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
5/23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
5/16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
5/16
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
5/7
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS